Volume 3, Issue 5, Pages (May 2013)

Slides:



Advertisements
Similar presentations
Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein.
Advertisements

The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo by Maurice Reimann, Christoph Loddenkemper, Cornelia.
Volume 21, Issue 12, Pages (December 2017)
Volume 16, Issue 3, Pages e4 (March 2014)
Increasing genomic instability during cancer therapy in a patient with Li-Fraumeni syndrome  Nadine Schuler, Jan Palm, Sabine Schmitz, Yvonne Lorat, Claudia.
Vemurafenib Induces Senescence Features in Melanoma Cells
Volume 19, Issue 7, Pages (July 2017)
Volume 12, Issue 1, Pages (January 2013)
MK-8776, a novel Chk1 inhibitor, exhibits an improved radiosensitizing effect compared to UCN-01 by exacerbating radiation-induced aberrant mitosis  Motofumi.
Volume 15, Issue 4, Pages (April 2012)
Volume 48, Issue 3, Pages (November 2012)
Anthony J. Cesare, Makoto T. Hayashi, Laure Crabbe, Jan Karlseder 
Volume 2, Issue 1, Pages (July 2002)
Volume 30, Issue 1, Pages (April 2008)
Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein.
Volume 11, Issue 6, Pages (June 2012)
Volume 6, Issue 1, Pages (January 2014)
Volume 43, Issue 4, Pages (August 2011)
Valentina Manfé, Edyta Biskup, Peter Johansen, Maria R
DNAPKcs is required for DNA repair in the presence of androgen.
Thy-1/β3 Integrin Interaction-Induced Apoptosis of Dermal Fibroblasts Is Mediated by Up-Regulation of FasL Expression  Manuela Schmidt, Danny Gutknecht,
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Volume 13, Issue 8, Pages (November 2015)
Volume 17, Issue 1, Pages (January 2010)
SOX7 Is Required for Muscle Satellite Cell Development and Maintenance
Volume 26, Issue 2, Pages (February 2018)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Generating Late-Onset Human iPSC-Based Disease Models by Inducing Neuronal Age- Related Phenotypes through Telomerase Manipulation  Elsa Vera, Nazario.
The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo  Emmy W. Verschuren, Juha Klefstrom,
miR-34a and the Cardiomyopathy of Senescence: SALT PNUTS, SALT PNUTS!
Volume 16, Issue 2, Pages (July 2016)
Modeling the Therapeutic Efficacy of p53 Restoration in Tumors
Volume 7, Issue 4, Pages (May 2014)
Volume 14, Issue 8, Pages (March 2016)
Volume 4, Issue 3, Pages (March 2015)
Volume 25, Issue 3, Pages (March 2017)
Volume 22, Issue 4, Pages (January 2018)
Tumor Suppression by p53: Fall of the Triumvirate?
The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo  Emmy W. Verschuren, Juha Klefstrom,
Volume 3, Issue 4, Pages (October 2014)
Volume 6, Issue 1, Pages (January 2014)
Volume 17, Issue 1, Pages (January 2010)
Raymond L. Warters, Patrick J. Adamson, Christopher D. Pond, Sancy A
A Genetic Screen Identifies TCF3/E2A and TRIAP1 as Pathway-Specific Regulators of the Cellular Response to p53 Activation  Zdenek Andrysik, Jihye Kim,
Volume 9, Issue 1, Pages (October 2014)
Shane M. Harding, Jonathan A. Boiarsky, Roger A. Greenberg 
Volume 48, Issue 3, Pages (November 2012)
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Blinded by the Light: The Growing Complexity of p53
Masayuki Yamashita, Eriko Nitta, Toshio Suda  Cell Stem Cell 
Volume 35, Issue 4, Pages (August 2009)
Volume 11, Issue 11, Pages (June 2015)
Volume 31, Issue 1, Pages (July 2008)
Activin Signals through SMAD2/3 to Increase Photoreceptor Precursor Yield during Embryonic Stem Cell Differentiation  Amy Q. Lu, Evgenya Y. Popova, Colin.
New Histone Incorporation Marks Sites of UV Repair in Human Cells
Volume 3, Issue 5, Pages (May 2013)
Volume 8, Issue 3, Pages (January 1998)
Volume 16, Issue 2, Pages (February 2009)
Nox1 as a potential therapeutic target to inhibit matricellular-mediated endothelial senescence. Nox1 as a potential therapeutic target to inhibit matricellular-mediated.
Volume 17, Issue 4, Pages (April 2010)
Lorn Kategaya, Senthil K. Perumal, Jeffrey H. Hager, Lisa D. Belmont
Volume 19, Issue 9, Pages (May 2017)
Volume 24, Issue 12, Pages (September 2018)
Lapatinib reduces IGF-I signaling in trastuzumab-resistant cells.
Proapoptotic Function of the Retinoblastoma Tumor Suppressor Protein
Volume 13, Issue 1, Pages (October 2015)
Volume 25, Issue 3, Pages (March 2017)
Volume 13, Issue 11, Pages (December 2015)
Volume 15, Issue 4, Pages (April 2016)
Yun-Gui Yang, Tomas Lindahl, Deborah E. Barnes  Cell 
Presentation transcript:

Volume 3, Issue 5, Pages 1339-1345 (May 2013) p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell- Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa  Liz J. Valente, Daniel H.D. Gray, Ewa M. Michalak, Josefina Pinon-Hofbauer, Alex Egle, Clare L. Scott, Ana Janic, Andreas Strasser  Cell Reports  Volume 3, Issue 5, Pages 1339-1345 (May 2013) DOI: 10.1016/j.celrep.2013.04.012 Copyright © 2013 The Authors Terms and Conditions

Cell Reports 2013 3, 1339-1345DOI: (10.1016/j.celrep.2013.04.012) Copyright © 2013 The Authors Terms and Conditions

Figure 1 Cells from p21−/−puma−/−noxa−/− Mice Are Resistant to p53-Mediated Induction of Apoptosis, G1/S Cell-Cycle Arrest, and Senescence (A) Thymocytes from WT, p21−/−puma−/−noxa−/−, and p53−/− mice were left untreated, exposed to 1.25 Gy γ-irradiation, or treated with 1 μg/ml etoposide or 10 μg/ml ionomycin in vitro. Cell viability was assessed after 24 hr by Annexin-V/PI staining followed by flow cytometric analysis. Data represent mean percentage Annexin-Vneg PIneg cells relative to medium controls. (B) Activated (proliferating) T lymphoblasts from WT, p21−/−puma−/−noxa−/−, and p53−/− mice were either left untreated or exposed to 1.25 Gy γ-irradiation and then cultured for an additional 8 hr. Distribution of cells within the different stages of the cell cycle (G0/G1, S, G2/M) was determined by PI staining followed by flow cytometric analysis. Data represent mean percentage of S phase cells ± SEM. (C) Dermal fibroblasts from WT, p21−/−puma−/−noxa−/−, and p53−/− mice were either left untreated or treated with 2 μg/ml etoposide and cultured for 96 hr. Induction of cellular senescence was determined by SA-β-galactosidase staining. Representative images of SA-β-galactosidase-stained cells. Quantitative analysis of % SA-β-galactosidase+ cells is shown; n=5 images/mouse (10× objective) were counted. For (A)–(C), n = 3–4 mice/genotype. Data represent mean ± SEM. *p < 0.001. Cell Reports 2013 3, 1339-1345DOI: (10.1016/j.celrep.2013.04.012) Copyright © 2013 The Authors Terms and Conditions

Figure 2 p21−/−puma−/−noxa−/− Mice Are Not Predisposed to Spontaneous Development of Cancer WT, p21−/−puma−/−noxa−/−, and p53−/− mice (all on a C57BL/6 background; see Experimental Procedures for how they were generated) were aged and monitored for tumor development (n = mice/genotype *p < 0.0001). Cell Reports 2013 3, 1339-1345DOI: (10.1016/j.celrep.2013.04.012) Copyright © 2013 The Authors Terms and Conditions

Figure 3 Loss of p53 but Not Combined Loss of p21, Puma, and Noxa Delays Resolution of DNA Damage Foci and Impairs Induction of Genes Implicated (A) Dermal fibroblasts from WT, p21−/−puma−/−noxa−/−, or p53−/− mice were either left untreated (UT) or exposed to 10 Gy γ-irradiation and subjected to analysis after 1, 6, and 24 hr. Cells were analyzed by immunofluorescent staining for the presence of γ-H2AX foci (green; a marker for detection of double-strand DNA breaks and initiation of repair). Counterstaining with DAPI (blue) was used to label all nuclei. (i) γ-H2AX staining alone; (ii) γ-H2AX staining and DAPI staining. Data are representative of analysis of n = 3 mice/genotype. (B) Quantification of γ-H2AX foci in dermal fibroblasts from WT, p21−/−puma−/−noxa−/−, or p53−/− mice that had been either left untreated (UT) or treated with 10 Gy γ-irradiation (analysis was performed after 1, 6, and 24 hr). Data represent percentage of cells with >40 foci/nuclei. Confocal images from UT, n = 1 mouse/genotype; 1 hr, n = 1–3 mice/genotype; 6 hr, n = 2 mice/genotype; 24 hr, n = 1–3 mice/genotype, were analyzed with 50–100 cells/mouse analyzed per time point. (C) Thymocytes from WT, p21−/−puma−/−noxa−/−, or p53−/− mice were either left untreated or exposed to 5 Gy γ-irradiation and harvested after 6 hr in culture. Quantitative RT-PCR analysis of mRNA levels of p53 target genes implicated in the control of DNA repair was performed; mRNA levels were standardized to the control gene Hmbs and data are expressed relative to untreated thymocytes (cultured for 6 hr). n = 3 mice/genotype and data represent mean ± SEM. *p < 0.05. Cell Reports 2013 3, 1339-1345DOI: (10.1016/j.celrep.2013.04.012) Copyright © 2013 The Authors Terms and Conditions

Figure 4 Model for How p53 Suppresses Tumorigenesis p53’s transcriptional control of apoptosis (via Puma and Noxa), cell-cycle arrest, and senescence (via p21) appears largely dispensable for p53’s ability to suppress tumorigenesis. Note that a role for cell senescence in p53-mediated tumor suppression cannot be fully excluded on the basis of our results (reflected by a faint dotted line) since induction of senescence was only impaired in cells from the p21−/−puma−/−noxa−/− mice but abrogated in cells from the p53−/− mice (Figure 1C). These processes do, however, exert critical roles in p53-mediated cellular responses to acute DNA damage, but this acute DNA damage response is not essential for p53-mediated suppression of spontaneous tumor development (Christophorou et al., 2006). Instead, p53’s underappreciated ability to act as a “guardian of the genome,” facilitating coordination of DNA repair and/or control of metabolism (or control of currently unknown processes) is hypothesized to be essential for p53’s ability to suppress development of cancer. Cell Reports 2013 3, 1339-1345DOI: (10.1016/j.celrep.2013.04.012) Copyright © 2013 The Authors Terms and Conditions